Enveric Biosciences Inc (ENVB)

Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule...

Enveric Biosciences Announces Participation in 2026 BIO International Convention

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003

Studies are designed to evaluate the potential for the compound to interact with DNA and cause genetic mutations, a critical measure of safety...

Form 8-K - Current report